ALT Altimmune, Inc. - Common Stock
ALT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
ALT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
ALT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 4 26,7%
- Al 9 60,0%
- Tut 2 13,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
9 analist · 2026-08-19Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.12 | $-0.14 | 0.02% |
| 31 Mart 2026 | $-0.18 | $-0.25 | 0.07% |
| 31 Aralık 2025 | $-0.27 | $-0.25 | -0.02% |
| 30 Eylül 2025 | $-0.21 | $-0.28 | 0.07% |
| 30 Haziran 2025 | $-0.27 | $-0.33 | 0.06% |
| 31 Mart 2025 | $-0.26 | $-0.37 | 0.11% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| R&D Expense | $66M | $82M | $66M | $71M | $75M | $50M | $18M | $18M | $18M | $7M | $5M | $9M | |
| SG&A Expense | $28M | $21M | $18M | $17M | $15M | $13M | $9M | $10M | $8M | $7M | $6M | $11M | |
| Operating Expenses | $95M | $103M | $96M | $88M | $101M | $63M | $27M | $53M | $63M | $14M | $14M | $20M | |
| Operating Income | $-94M | $-103M | $-96M | $-88M | $-97M | $-55M | $-21M | $-43M | $-52M | $-11M | $-3M | $-10M | |
| Interest Expense | · | · | $35.0K | $8.0K | $5.0K | $9.4K | $2.2K | $297.1K | $162.1K | $38.5K | $54.6K | $210.4K | |
| Interest Income | $8M | $8M | $7M | $3M | $203.0K | $322.5K | $843.4K | $226.6K | $47.6K | $1.0K | · | · | |
| Other Non-op | $-190.0K | $48.0K | $166.0K | $-32.0K | $-374.0K | $24.1K | $15.1K | $277.9K | $5.7K | $42.3K | $8.1K | $-762 | |
| Pretax Income | $-89M | $-95M | $-88M | $-85M | $-97M | $-54M | $-21M | $-45M | $-52M | $-11M | $-3M | $-10M | |
| Income Tax | $-681.0K | · | · | $-197.0K | · | $-5M | $-58.5K | $-6M | $-6M | $0 | $61.7K | $61.7K | |
| Net Income | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| EPS (Basic) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.97 | $-0.05 | $-0.17 | |
| EPS (Diluted) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.95 | $-0.05 | $-0.17 | |
| Shares (Basic) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,306,962 | 63,986,013 | 57,535,325 | |
| Shares (Diluted) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,657,802 | 63,986,013 | 57,535,325 | |
| EBITDA | $-94M | $-103M | $-96M | $-88M | $-96M | $-55M | $-21M | $-43M | · | $-11M | $-3M | $-10M |
Bilanço 29
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $37M | $135M | $111M | $190M | $116M | $9M | $34M | $9M | $3M | $16M | $19M | |
| Short-term Investments | $230M | $95M | $63M | $74M | · | $100M | $28M | · | · | $67M | $0 | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $400.0K | |
| Prepaid Expense | $3M | $2M | $7M | $5M | $8M | $2M | $470.2K | $548.1K | $994.3K | $420.4K | $181.7K | $199.2K | |
| Current Assets | $278M | $137M | $210M | $193M | $204M | $230M | $39M | $39M | $23M | $4M | $17M | $19M | |
| PP&E (Net) | $312.0K | $413.0K | $651.0K | $1M | $1M | $1M | $1M | $1M | $603.1K | $177.9K | $233.7K | $325.8K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $3M | |
| Accum. Depreciation | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $951.8K | $905.3K | $2M | $2M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | · | $19M | $22M | $2M | |
| Intangibles | · | $0 | $0 | $12M | $12M | $13M | $13M | $14M | $39M | $15M | · | · | |
| Other Non-current Assets | $1M | $2M | $363.0K | $615.0K | $872.0K | $977.2K | $128.5K | $183.7K | $238.9K | $22.2K | $53.4K | $53.4K | |
| Total Assets | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Accounts Payable | $3M | $211.0K | $2M | $5M | $2M | $612.3K | $18.2K | $372.9K | $129.1K | $2M | $521.1K | $391.4K | |
| Accrued Liabilities | · | · | · | · | · | $11M | $4M | $4M | $4M | $3M | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | $71.6K | $49.7K | $458.6K | · | · | |
| Current Liabilities | $15M | $10M | $12M | $17M | $18M | $12M | $4M | $5M | $4M | $5M | $2M | $3M | |
| Capital Leases | $1M | $1M | $175.0K | $672.0K | $1M | $1M | $1M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $58.5K | $6M | $442.6K | $380.8K | $319.0K | |
| Other Non-current Liabilities | $6M | $5M | $40.0K | $60.0K | $80.0K | $110.3K | $130.2K | $140.1K | $160.0K | $442.6K | $433.4K | $493.1K | |
| Total Liabilities | $55M | $16M | $17M | $22M | $20M | $19M | $9M | $6M | $14M | $6M | $3M | $4M | |
| Long-term Debt | $34M | · | · | · | · | · | · | $500.0K | $500.0K | $526.0K | · | · | |
| Total Debt | $34M | · | · | $5M | $1M | $2M | $2M | $71.6K | · | · | $0 | $746.1K | |
| Common Stock | $11.0K | $7.0K | $7.0K | $5.0K | $4.0K | $3.7K | $1.5K | $876 | $61 | $692 | $6.4K | $6.4K | |
| Paid-in Capital | $879M | $690M | $665M | $568M | $497M | $417M | $188M | $170M | $122M | $71M | $240M | $239M | |
| Retained Earnings | $-649M | $-561M | $-466M | $-378M | $-293M | $-186M | $-137M | $-117M | $-78M | $-31M | $-224M | $-220M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $0 | $-229.5K | |
| Stockholders' Equity | $225M | $124M | $194M | $185M | $199M | $226M | $46M | $48M | $39M | $32M | $43M | $18M | |
| Liabilities + Equity | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Shares Outstanding | 110,882,735 | 72,352,701 | 70,677,400 | 49,199,845 | 40,993,768 | 37,142,946 | 15,312,167 | 9,078,238 | 608,499 | 6,917,204 | 64,382,086 | 63,603,303 |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $-205.0K | $551.0K | $428.9K | $387.3K | · | · | · | · | · | |
| Stock-based Comp | $16M | $14M | $11M | $8M | $6M | $3M | $1M | $773.2K | $1M | $965.4K | $613.0K | $2M | |
| Deferred Tax | $-681.0K | · | · | · | · | · | $-58.5K | $-6M | $-3M | $61.8K | $61.7K | $61.7K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $3M | $0 | |
| Other Non-cash | · | · | · | $14M | $13M | $12M | · | · | · | · | · | · | |
| Operating Cash Flow | $-68M | $-80M | $-76M | $-63M | $-78M | $-34M | $-10M | $-9M | $-20M | $-6M | $-3M | $-8M | |
| CapEx | $11.0K | · | $47.0K | $126.0K | $12M | $204.0K | $1.2K | $975.4K | $112.4K | $125.0K | $86.5K | $92.3K | |
| Investing Cash Flow | $-132M | $-28M | $14M | $-73M | $88M | $-72M | $-28M | $-1M | $14M | · | · | · | |
| Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Net Stock Activity | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Financing Cash Flow | $207M | $10M | $86M | $57M | $65M | $213M | $13M | $32M | $16M | · | · | · | |
| Net Change in Cash | $7M | $-98M | $24M | $-79M | $74M | $107M | $-25M | $22M | $9M | $138M | $-3M | $8M | |
| Free Cash Flow | $-68M | · | $-76M | $-63M | $-90M | $-35M | $-10M | $-10M | · | $201M | $-3M | $-9M | |
| Levered FCF | · | · | · | $-63M | · | $-35M | $-10M | $-11M | · | · | $-3M | $-9M |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% | -669.5% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| Net Margin | -214861.0% | -475295.0% | -20762.2% | 124577.9% | -2201.4% | -599.2% | -353.7% | -379.2% | · | 115286.4% | · | · | |
| Pretax Margin | -216522.0% | -475295.0% | -20762.2% | 124867.7% | -2201.4% | -665.4% | -354.7% | -438.7% | · | 121929.0% | · | · | |
| EBITDA Margin | -230461.0% | -515860.0% | -22518.5% | 129330.9% | -2184.9% | -665.9% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| ROA | -42.0% | -54.3% | -42.4% | -39.8% | -41.9% | -32.8% | -37.7% | -66.5% | · | 158.5% | -16.4% | -50.9% | |
| ROE | -45.6% | -74.0% | -51.3% | -43.4% | -47.5% | -23.1% | -43.2% | -89.0% | · | 619.4% | -19.7% | -77.8% | |
| ROIC | -36.2% | · | · | -46.1% | · | -21.7% | -45.2% | -76.5% | · | -54.7% | -20.8% | -53.9% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 | 19.2 | 10.0 | 8.7 | · | 1.1 | 7.9 | 7.5 | |
| Quick Ratio | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 | 18.0 | 9.5 | 7.4 | · | 1.1 | 7.1 | 7.4 | |
| Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -2740.8 | -10967.5 | -17134.7 | -5816.7 | -9565.5 | -144.2 | · | · | -62.3 | -48.4 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.1 | 0.1 | 0.2 | · | 0.0 | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 105.0% | -95.3% | · | · | -46.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -83.5% | -62.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -65.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| Net Income TTM | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| Market Cap | $400M | $522M | $795M | $809M | $376M | $419M | $29M | $19M | · | · | · | · | |
| Enterprise Value | $161M | · | · | $629M | $187M | $205M | $-6M | $-15M | · | · | · | · | |
| P/E | -3.6 | -5.4 | -6.8 | -9.1 | -3.9 | -5.9 | 0.6 | 0.7 | 20.4 | · | · | · | |
| P/S | 9763.1 | 26083.1 | 1866.5 | -11902.0 | 85.1 | 51.2 | 5.0 | 1.8 | · | · | · | · | |
| P/B | 1.8 | 4.2 | 4.1 | 4.4 | 1.9 | 1.9 | 0.6 | 0.4 | · | · | · | · | |
| P / Tangible Book | 1.8 | 4.2 | 4.1 | 4.7 | 2.0 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -5.9 | -6.5 | -10.5 | -12.9 | -4.8 | -12.2 | -3.0 | -2.0 | · | · | · | · | |
| P / FCF | -5.9 | · | -10.5 | -12.9 | -4.2 | -12.1 | -3.0 | -1.8 | · | · | · | · | |
| EV / EBITDA | -1.7 | · | · | -7.2 | -1.9 | -3.8 | 0.3 | 0.3 | · | · | · | · | |
| EV / FCF | -2.4 | · | · | -10.0 | -2.1 | -5.9 | 0.7 | 1.4 | · | · | · | · | |
| EV / Revenue | 3929.7 | · | · | -9250.6 | 42.3 | 25.0 | -1.1 | -1.4 | · | · | · | · | |
| Earnings Yield | -27.7% | -18.6% | -14.8% | -11.0% | -25.7% | -16.9% | 154.5% | 141.8% | 4.9% | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $26.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $37.0K | $362.0K | $6.0K | $21.0K | $-110.0K | $2.0K | |
| R&D Expense | $19M | $16M | $18M | $15M | $17M | $16M | $20M | $20M | $21M | $21M | $17M | $18M | $13M | $17M | $19M | $20M | |
| SG&A Expense | $8M | $8M | $11M | $6M | $6M | $6M | $5M | $5M | $6M | $5M | $4M | $5M | $5M | $5M | $4M | $4M | |
| Operating Expenses | $26M | $24M | $29M | $21M | $23M | $22M | $25M | $25M | $27M | $27M | $34M | $23M | $18M | $22M | $23M | $25M | |
| Operating Income | $-26M | $-24M | $-29M | $-21M | $-23M | $-22M | $-25M | $-25M | $-27M | $-27M | $-34M | $-23M | $-18M | $-22M | $-23M | $-25M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1.0K | · | $29.0K | $2.0K | $2.0K | $-183.0K | $64.0K | |
| Interest Income | $5M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-op | $-25.0K | $-152.0K | $-27.0K | $-86.0K | $-92.0K | $15.0K | $118.0K | $18.0K | $-76.0K | $-12.0K | $20.0K | $14.0K | $113.0K | $19.0K | $-217.0K | $50.0K | |
| Pretax Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | · | · | $-22M | $-24M | |
| Income Tax | · | · | $0 | $0 | $0 | $-681.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $-197.0K | |
| Net Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | $-16M | $-20M | $-22M | $-24M | |
| EPS (Basic) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| EPS (Diluted) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| Shares (Basic) | 185,443,736 | 124,461,818 | -158,339,190 | 89,418,028 | 81,477,548 | 75,547,746 | -141,807,472 | 71,084,787 | 70,924,371 | 70,801,713 | -101,203,660 | 53,633,354 | 50,691,558 | 50,125,685 | -93,832,266 | 49,286,535 | |
| Shares (Diluted) | 185,443,736 | 124,461,818 | -158,339,190 | 89,418,028 | 81,477,548 | 75,547,746 | -141,807,472 | 71,084,787 | 70,924,371 | 70,801,713 | -101,203,660 | 53,633,354 | 50,691,558 | 50,125,685 | -93,832,266 | 49,286,535 | |
| EBITDA | $-26M | $-24M | · | $-21M | $-23M | $-22M | · | $-25M | $-27M | $-27M | · | $-23M | $-18M | $-22M | · | $-25M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $98M | $44M | $61M | $183M | $49M | $37M | $31M | $57M | $79M | $135M | $87M | $102M | $105M | $111M | $127M | |
| Short-term Investments | $263M | $234M | $230M | $150M | · | $101M | $95M | $108M | $108M | $103M | $63M | $54M | $58M | $61M | $74M | $74M | |
| Prepaid Expense | $5M | $1M | $3M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $7M | $8M | $6M | $4M | $5M | $5M | |
| Current Assets | $335M | $335M | $278M | $217M | $188M | $155M | $137M | $146M | $171M | $188M | $210M | $153M | $170M | $173M | $193M | $211M | |
| PP&E (Net) | $60.0K | $208.0K | $312.0K | $337.0K | $364.0K | $384.0K | $413.0K | $446.0K | $483.0K | $544.0K | $651.0K | $765.0K | $882.0K | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $1M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | $12M | |
| Other Non-current Assets | $90.0K | $746.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $299.0K | $363.0K | $425.0K | $483.0K | $546.0K | $615.0K | $682.0K | |
| Total Assets | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Accounts Payable | $1M | $2M | $3M | $5M | $851.0K | $1M | $211.0K | $1M | $3M | $4M | $2M | $3M | $4M | $5M | $5M | $1M | |
| Current Liabilities | $13M | $11M | $15M | $13M | $9M | $10M | $10M | $9M | $15M | $11M | $12M | $12M | $11M | $15M | $17M | $16M | |
| Capital Leases | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $44.0K | $175.0K | $303.0K | $429.0K | $552.0K | $672.0K | $788.0K | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $5M | $16.0K | $5M | $26.0K | $31.0K | $37.0K | $40.0K | $46.0K | $52.0K | $56.0K | $60.0K | $66.0K | |
| Total Liabilities | $53M | $52M | $55M | $33M | $29M | $15M | $16M | $14M | $21M | $15M | $17M | $16M | $16M | $19M | $22M | $20M | |
| Long-term Debt | $35M | $35M | $34M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $35M | $35M | · | $14M | $14M | · | · | · | · | · | · | $4M | $4M | $4M | · | $5M | |
| Common Stock | $19.0K | $13.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $1.18B | $961M | $879M | $813M | $770M | $728M | $690M | $676M | $673M | $669M | $665M | $590M | $587M | $571M | $568M | $567M | |
| Retained Earnings | $-695M | $-672M | $-649M | $-622M | $-603M | $-581M | $-561M | $-538M | $-515M | $-491M | $-466M | $-435M | $-414M | $-398M | $-378M | $-356M | |
| AOCI | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $474M | $284M | $225M | $186M | $161M | $142M | $124M | $133M | $153M | $173M | $194M | $150M | $168M | $168M | $185M | $205M | |
| Liabilities + Equity | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Shares Outstanding | 194,474,154 | 130,221,154 | 110,882,735 | 95,598,665 | 85,076,300 | 77,825,450 | 72,352,701 | 71,124,407 | 71,046,267 | 70,899,134 | 70,677,400 | 52,858,920 | 52,657,661 | 49,286,710 | 49,199,845 | 49,161,637 |
Nakit Akışı 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $-552.0K | $-505.0K | $-356.0K | · | $-141.0K | |
| Stock-based Comp | $3M | $3M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $-681.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-24M | $-21M | $-19M | $-12M | $-19M | $-17M | $-18M | $-27M | $-18M | $-16M | $-17M | $-20M | $-19M | $-19M | $-17M | $-15M | |
| CapEx | $32.0K | $21.0K | $1.0K | $0 | · | · | · | · | · | · | $0 | $0 | $-4.0K | $51.0K | $38.0K | $60.0K | |
| Investing Cash Flow | $-221M | $-4M | $-79M | $-149M | $101M | $-5M | $14M | $1M | $-4M | $-40M | $-8M | $4M | $4M | $13M | $981.0K | $-25M | |
| Debt Issued | · | · | $20M | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $-89.0K | $9M | $62M | $40M | $38M | $35M | · | · | · | · | $73M | $510.0K | · | · | $0 | $32M | |
| Net Stock Activity | · | $9M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $211M | $78M | $81M | $39M | $52M | $34M | $10M | $266.0K | $-46.0K | $-261.0K | $73M | $588.0K | $13M | $-302.0K | $-43.0K | $32M | |
| Net Change in Cash | $-35M | $54M | $-17M | $-122M | $134M | $12M | $5M | $-26M | $-22M | $-56M | $48M | $-15M | $-2M | $-6M | $-16M | $-8M | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | · | · | · | · | $-19M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -103614.3% | · | -1237600.0% | |
| Net Margin | · | · | · | -380280.0% | -442920.0% | -391500.0% | · | -456900.0% | -492800.0% | -487880.0% | · | -5710.2% | -267683.3% | -95590.5% | · | -1175800.0% | |
| Pretax Margin | · | · | · | -380280.0% | -442920.0% | -405120.0% | · | · | · | · | · | -5710.2% | · | · | · | -1185650.0% | |
| EBITDA Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -105309.5% | · | -1237600.0% | |
| ROA | -6.4% | -9.2% | · | -10.4% | -12.2% | -11.3% | · | -14.5% | -13.8% | -13.0% | · | -10.5% | -8.2% | -10.2% | · | -10.2% | |
| ROE | -7.2% | -10.6% | · | -11.9% | -14.1% | -12.4% | · | -16.1% | -15.4% | -14.3% | · | -11.6% | -8.9% | -11.4% | · | -11.3% | |
| ROIC | · | · | · | · | · | -14.8% | · | · | · | · | · | · | · | · | · | -11.7% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.8 | 29.6 | · | 17.2 | 20.4 | 15.8 | · | 16.9 | 11.3 | 16.5 | · | 12.9 | 14.8 | 11.6 | · | 13.4 | |
| Quick Ratio | 26.1 | 29.3 | · | 16.7 | 19.9 | 15.3 | · | 16.1 | 10.9 | 16.1 | · | 11.9 | 14.0 | 11.1 | · | 12.8 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -26794.0 | · | -777.2 | -9003.5 | -10879.5 | · | -386.8 |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.0K | $20.0K | · | $20.0K | $20.0K | $20.0K | · | $377.0K | $378.0K | $394.0K | · | $391.0K | $37.0K | $63.0K | · | $200.0K | |
| Net Income TTM | $-87M | $-83M | · | $-84M | $-89M | $-91M | · | $-93M | $-86M | $-81M | · | $-80M | $-80M | $-83M | · | $-97M | |
| Market Cap | $591M | $401M | · | $360M | $329M | $389M | · | $437M | $472M | $722M | · | $137M | $186M | $208M | · | $628M | |
| Enterprise Value | $300M | $104M | · | $164M | $160M | · | · | · | · | · | · | $959.2K | $30M | $47M | · | $430M | |
| P/E | -3.9 | -3.3 | · | -3.6 | -3.2 | -3.9 | · | -4.4 | -4.8 | -7.0 | · | -1.6 | -2.2 | -2.4 | · | -5.9 | |
| P/S | 29560.1 | 20054.1 | · | 18020.3 | 16462.3 | 19456.4 | · | 1158.4 | 1249.9 | 1831.9 | · | 351.5 | 5023.8 | 3301.4 | · | 3139.0 | |
| P/B | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.1 | |
| P / Tangible Book | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.3 | |
| P / Cash Flow | · | -19.2 | · | · | · | -23.1 | · | · | · | -44.1 | · | · | · | -10.7 | · | · | |
| P / FCF | · | -19.1 | · | · | · | · | · | · | · | · | · | · | · | -10.7 | · | · | |
| EV / EBITDA | -11.4 | -4.3 | · | -7.9 | -7.0 | · | · | · | · | · | · | -0.0 | -1.7 | -2.1 | · | -17.4 | |
| EV / FCF | · | -5.0 | · | · | · | · | · | · | · | · | · | · | · | -2.4 | · | · | |
| EV / Revenue | 14983.1 | 5202.3 | · | 8203.8 | 8023.6 | · | · | · | · | · | · | 2.5 | 813.3 | 740.6 | · | 2152.4 | |
| Earnings Yield | -25.7% | -29.9% | · | -28.1% | -31.0% | -25.4% | · | -22.8% | -21.1% | -14.2% | · | -61.2% | -45.9% | -41.2% | · | -16.8% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $41.0K | $20.0K | $426.0K | $-68.0K | $4M |
| Faaliyet Kâr Marjı % | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% |
| Net Gelir | $-88M | $-95M | $-88M | $-85M | $-97M |
| Seyreltilmiş Hisse Başı Kâr | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.2 | — | — | 0.0 | 0.0 |
| Cari Oran | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 |
| Cari Oran | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-68M | — | $-76M | $-63M | $-90M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 238 dosya · $355.5M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 65 (+39 önceki Ç'ye göre) | 16 (-17 önceki Ç'ye göre) | 78 (-4 önceki Ç'ye göre) | 38 (-1 önceki Ç'ye göre) | +79.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Deep Track Capital, LP | $58.520.000 | 19.250.000 | 16,46% | Hisse senetleri |
| STATE STREET CORP | $36.779.562 | 12.098.540 | 10,35% | Hisse senetleri |
| TCG Crossover Management, LLC | $30.400.000 | 10.000.000 | 8,55% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.860.366 | 8.177.752 | 6,99% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22.284.006 | 7.330.265 | 6,27% | Hisse senetleri |
| VIKING GLOBAL INVESTORS LP | $20.368.000 | 6.700.000 | 5,73% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $19.760.000 | 6.500.000 | 5,56% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $13.042.903 | 4.289.189 | 3,67% | Hisse senetleri |
| Woodline Partners LP | $10.336.948 | 3.400.312 | 2,91% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $10.059.731 | 3.309.122 | 2,83% | Hisse senetleri |
| Trails Edge Capital Partners, LP | $8.086.400 | 2.660.000 | 2,27% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $7.238.672 | 2.381.142 | 2,04% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $5.713.595 | 1.879.472 | 1,61% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.469.872 | 1.799.300 | 1,54% | Alım opsiyonu |
| GREAT POINT PARTNERS LLC | $5.293.345 | 1.741.232 | 1,49% | Hisse senetleri |
| Weiss Asset Management LP | $4.653.641 | 1.530.803 | 1,31% | Hisse senetleri |
| Nantahala Capital Management, LLC | $4.560.000 | 1.500.000 | 1,28% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $3.930.723 | 1.293.001 | 1,11% | Hisse senetleri |
| Cormorant Asset Management, LP | $3.800.000 | 1.250.000 | 1,07% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $2.865.979 | 793.900 | 0,81% | Hisse senetleri |
| VANGUARD GROUP INC | $2.531.996 | 701.384 | 0,71% | Hisse senetleri |
| MARSHALL WACE, LLP | $2.424.799 | 797.631 | 0,68% | Hisse senetleri |
| Ghisallo Capital Management LLC | $2.280.000 | 750.000 | 0,64% | Hisse senetleri |
| FMR LLC | $2.276.297 | 748.782 | 0,64% | Hisse senetleri |
| BlackRock, Inc. | $2.190.606 | 720.594 | 0,62% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $2.024.707 | 666.022 | 0,57% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.918.240 | 631.000 | 0,54% | Alım opsiyonu |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.898.477 | 624.499 | 0,53% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $1.789.581 | 588.678 | 0,50% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $1.711.815 | 563.097 | 0,48% | Hisse senetleri |
| Point72 Asset Management, L.P. | $1.480.127 | 486.884 | 0,42% | Hisse senetleri |
| Rock Springs Capital Management LP | $1.433.254 | 471.465 | 0,40% | Hisse senetleri |
| Beirne Wealth Consulting Services, LLC | $1.282.449 | 421.858 | 0,36% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $1.128.375 | 371.176 | 0,32% | Hisse senetleri |
| BARCLAYS PLC | $1.021.313 | 335.958 | 0,29% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $990.128 | 325.700 | 0,28% | Satım opsiyonu |
| RHUMBLINE ADVISERS | $941.193 | 309.606 | 0,26% | Hisse senetleri |
| LMR Partners LLP | $912.000 | 300.000 | 0,26% | Hisse senetleri |
| CITIGROUP INC | $857.496 | 282.071 | 0,24% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $810.680 | 266.671 | 0,23% | Hisse senetleri |
| MANGROVE PARTNERS IM, LLC | $727.411 | 239.280 | 0,20% | Hisse senetleri |
| Baird Financial Group, Inc. | $722.067 | 237.522 | 0,20% | Hisse senetleri |
| BROWN WEALTH MANAGEMENT, LLC | $717.853 | 236.136 | 0,20% | Hisse senetleri |
| JANE STREET GROUP, LLC | $691.296 | 227.400 | 0,19% | Alım opsiyonu |
| Rafferty Asset Management, LLC | $684.182 | 225.060 | 0,19% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $652.300 | 214.574 | 0,18% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $637.478 | 168.200 | 0,18% | Alım opsiyonu |
| Squarepoint Ops LLC | $615.235 | 202.380 | 0,17% | Hisse senetleri |
| ALPS ADVISORS INC | $600.017 | 197.374 | 0,17% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $584.799 | 192.368 | 0,16% | Hisse senetleri |
| Jump Financial, LLC | $577.600 | 190.000 | 0,16% | Hisse senetleri |
| Man Group plc | $528.571 | 173.872 | 0,15% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $506.063 | 166.468 | 0,14% | Hisse senetleri |
| Knoll Capital Management, LLC | $486.400 | 160.000 | 0,14% | Hisse senetleri |
| Birchview Capital, LP | $464.150 | 152.681 | 0,13% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $433.818 | 140.850 | 0,12% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $407.053 | 133.899 | 0,11% | Hisse senetleri |
| Brevan Howard Capital Management LP | $397.574 | 130.781 | 0,11% | Hisse senetleri |
| XTX Topco Ltd | $389.388 | 128.088 | 0,11% | Hisse senetleri |
| CITADEL ADVISORS LLC | $389.120 | 128.000 | 0,11% | Satım opsiyonu |
| Virtus Investment Advisers, LLC | $381.104 | 125.363 | 0,11% | Hisse senetleri |
| WEALTH EFFECTS LLC | $372.856 | 122.650 | 0,10% | Hisse senetleri |
| LPL Financial LLC | $370.734 | 121.952 | 0,10% | Hisse senetleri |
| MetLife Investment Management, LLC | $355.242 | 116.856 | 0,10% | Hisse senetleri |
| PROFUND ADVISORS LLC | $345.338 | 113.598 | 0,10% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $340.285 | 111.936 | 0,10% | Hisse senetleri |
| Jefferies Financial Group Inc. | $334.400 | 110.000 | 0,09% | Hisse senetleri |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $314.640 | 103.500 | 0,09% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $314.257 | 103.374 | 0,09% | Hisse senetleri |
| Summit Financial Wealth Advisors, LLC | $313.996 | 103.288 | 0,09% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $312.582 | 102.823 | 0,09% | Hisse senetleri |
| Mariner, LLC | $307.407 | 101.123 | 0,09% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $304.000 | 100.000 | 0,09% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $278.276 | 91.538 | 0,08% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $265.392 | 87.300 | 0,07% | Hisse senetleri |
| Grantham, Mayo, Van Otterloo & Co. LLC | $254.864 | 83.837 | 0,07% | Hisse senetleri |
| Invesco Ltd. | $241.625 | 79.482 | 0,07% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $228.137 | 75.045 | 0,06% | Hisse senetleri |
| KINGSWOOD WEALTH ADVISORS, LLC | $226.480 | 74.500 | 0,06% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $217.664 | 71.600 | 0,06% | Hisse senetleri |
| Bank of New York Mellon Corp | $206.136 | 67.808 | 0,06% | Hisse senetleri |
| IEQ CAPITAL, LLC | $203.540 | 66.954 | 0,06% | Hisse senetleri |
| PVG ASSET MANAGEMENT CORP | $201.005 | 66.120 | 0,06% | Hisse senetleri |
| HSBC HOLDINGS PLC | $199.504 | 64.460 | 0,06% | Hisse senetleri |
| Leonteq Securities AG | $194.560 | 64.000 | 0,05% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $178.220 | 58.625 | 0,05% | Hisse senetleri |
| AXQ CAPITAL, LP | $172.702 | 56.810 | 0,05% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $172.499 | 56.743 | 0,05% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $163.728 | 43.200 | 0,05% | Satım opsiyonu |
| MERCER GLOBAL ADVISORS INC /ADV | $161.470 | 53.115 | 0,05% | Hisse senetleri |
| Corient Private Wealth LP | $161.219 | 53.032 | 0,05% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $160.351 | 52.747 | 0,05% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $158.189 | 52.036 | 0,04% | Hisse senetleri |
| Cetera Investment Advisers | $157.779 | 51.901 | 0,04% | Hisse senetleri |
| JANE STREET GROUP, LLC | $150.176 | 49.400 | 0,04% | Satım opsiyonu |
| Caption Management, LLC | $141.716 | 46.617 | 0,04% | Hisse senetleri |
| INTECH INVESTMENT MANAGEMENT LLC | $139.569 | 45.911 | 0,04% | Hisse senetleri |
| Quantbot Technologies LP | $138.721 | 45.632 | 0,04% | Hisse senetleri |
| Graham Capital Management, L.P. | $136.618 | 44.940 | 0,04% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $135.639 | 44.618 | 0,04% | Hisse senetleri |
Şirket yöneticileri 48 içeriden öğrenenler · 25 yöneticiler · 20 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Vipin K Garg | President and CEO | 02 Şubat 2025 M | 355.082 | 0 | 0 | $0 |
| William Enright | President and CEO | 25 Mayıs 2018 P | 365.839 | 0 | 0 | $0 |
| David P Wright | President and CEO | 11 Aralık 2009 P | 399.500 | 0 | 0 | $0 |
| Gregory L Weaver | Chief Financial Officer | 31 Temmuz 2026 A | 39.831 | 2 | 0 | $49.200 |
| Andrew Shutterly | Acting Chief Financial Officer | 31 Temmuz 2024 A | 11.372 | 0 | 0 | $0 |
| Richard I Eisenstadt | Chief Financial Officer | 30 Ocak 2024 M | 45.012 | 0 | 0 | $0 |
| William Michael Brown | Chief Financial Officer | 31 Temmuz 2021 A | 17.721 | 0 | 0 | $0 |
| Elizabeth Czerepak | CFO and EVP Corp. Development | 22 Eylül 2017 A | — | 0 | 0 | $0 |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | 21 Aralık 2016 M | 126.346 | 0 | 0 | $0 |
| Linda L Chang | SVP, CFO & Secretary | 07 Ocak 2015 M | 30.000 | 0 | 0 | $0 |
| Charles A. Reinhart III | SVP, Chief Financial Officer | 08 Aralık 2010 A | — | 0 | 0 | $0 |
| Kevin Price | President - PharmAthene UK,Ltd | 21 Ocak 2009 A | 2.500 | 0 | 0 | $0 |
| Jeffrey Michael Jones | COO | 11 Mart 2015 A | 27.544 | 0 | 0 | $0 |
| Scot M Roberts | Chief Scientific Officer | 31 Temmuz 2026 A | 113.699 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 01 Ekim 2025 A | — | 0 | 0 | $0 |
| Linda M Richardson | Chief Commercial Officer | 16 Eylül 2025 A | — | 0 | 0 | $0 |
| Raymond M Jordt | Chief Business Officer | 31 Temmuz 2025 A | 36.270 | 0 | 0 | $0 |
| Matthew Scott Harris | Chief Medical Officer | 31 Temmuz 2025 A | 16.087 | 0 | 0 | $0 |
| Sybil Tasker | Chief Medical Officer | 17 Haziran 2019 A | — | 0 | 0 | $0 |
| Wayne Morges | SVP, Reg. Affairs & Quality | 08 Aralık 2014 A | 35.532 | 0 | 0 | $0 |
| Francesca M Cook | SVP, Policy & Gov't Affairs | 08 Aralık 2014 A | 37.631 | 0 | 0 | $0 |
| Thomas Richard Fuerst | EVP, Chief Scientific Officer | 01 Aralık 2011 A | 15.000 | 0 | 0 | $0 |
| Valerie D Riddle | SVP, Medical Director | 31 Mayıs 2011 M | 44.436 | 0 | 0 | $0 |
| Joan Fusco | SVP, Operations | 06 Mayıs 2010 A | 36.730 | 0 | 0 | $0 |
| Christopher C Camut | VP, Gov't Contracts | 21 Ocak 2010 F | 46.777 | 0 | 0 | $0 |
| Mitchel Sayare | Yönetim kurulu üyesi | 01 Mayıs 2026 A | 26.363 | 0 | 0 | $0 |
| Teri L Lawver | Yönetim kurulu üyesi | 25 Eylül 2025 A | — | 0 | 0 | $0 |
| Wayne Pisano | Yönetim kurulu üyesi | 25 Eylül 2025 A | 8.498 | 0 | 0 | $0 |
| Klaus Schafer | Yönetim kurulu üyesi | 25 Eylül 2025 A | 9.179 | 0 | 0 | $0 |
| Philip Hodges | Yönetim kurulu üyesi | 25 Eylül 2025 A | 8.731 | 0 | 0 | $0 |
| Catherine A. Sohn | Yönetim kurulu üyesi | 25 Eylül 2025 A | 1.000 | 0 | 0 | $0 |
| Diane Jorkasky | Yönetim kurulu üyesi | 25 Eylül 2025 A | 0 | 0 | 0 | $0 |
| John Gill | Yönetim kurulu üyesi | 25 Eylül 2025 A | 0 | 0 | 0 | $0 |
| David Drutz | Yönetim kurulu üyesi | 19 Ağustos 2024 M | 55.524 | 0 | 0 | $0 |
| SCHAFFER DERACE L | Yönetim kurulu üyesi | 29 Aralık 2017 P | 589.453 | 0 | 0 | $0 |
| Jeffrey W. Runge | Yönetim kurulu üyesi | 20 Ocak 2017 M | 197.700 | 0 | 0 | $0 |
| Steven St Peter | Yönetim kurulu üyesi | 04 Ocak 2017 M | 205.004 | 0 | 0 | $0 |
| Eric I Richman | Yönetim kurulu üyesi | 22 Kasım 2016 M | 898.055 | 0 | 0 | $0 |
| Joel Mccleary | Yönetim kurulu üyesi | 31 Aralık 2014 A | 120.167 | 0 | 0 | $0 |
| Brian A Markison | Yönetim kurulu üyesi | 31 Aralık 2014 A | — | 0 | 0 | $0 |
| John Pappajohn | Yönetim kurulu üyesi | 23 Haziran 2011 A | 394.044 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | Yönetim kurulu üyesi | 23 Haziran 2010 A | — | 0 | 0 | $0 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% sahip | 15 Mayıs 2020 S | 1.687.250 | 0 | 0 | $0 |
| Truffle Capital S.A.S. | 10% sahip | 13 Şubat 2018 J | 76.700 | 0 | 0 | $0 |
| ANSBERT GADICKE | 10% sahip | 03 Ağustos 2007 A | — | 0 | 0 | $0 |
| Jerome Benedict Durso | — | 13 Ağustos 2026 P | 62.500 | 1 | 0 | $44.250 |
| Jordan P Karp | — | 03 Aralık 2012 A | 21.929 | 0 | 0 | $0 |
| Matthew P Kinley | — | 03 Ağustos 2007 P | 541.000 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 18 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Shah, Nimish, Koh, Bong | 25 Haziran 2020 | — | İlk başvuru | Pasif yatırım | SEC |
| Philip Hodges, Redmont Venture Partners, Inc., Redmont VAXN Capital Holdings, LLC, Paradigm Venture Partners, L.P. ×3 başvurular | 19 Ekim 2017 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 30 Mart 2016 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 12 Şubat 2016 | — | İlk başvuru | — | SEC |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., PRESCOTT GROUP AGGRESSIVE SMALL CAP, L.P., PRESCOTT GROUP AGGRESSIVE SMALL CAP II, L.P., PHIL FROHLICH ×6 başvurular | 02 Aralık 2013 | — | İlk başvuru | — | SEC |
| Theraclone Sciences, Inc. | 12 Ağustos 2013 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 27 Aralık 2010 | — | İlk başvuru | Pasif yatırım | SEC |
| Kelisia Holdings L imited, Panacea Biotec Limited | 18 Eylül 2009 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 04 Ağustos 2009 | — | İlk başvuru | Pasif yatırım | SEC |
| HealthCare Ventures VII, L.P., HealthCare Partners VII, L.P., James H. Cavanaugh, Ph.D., John Littlechild, Harold Werner, Augustine Lawlor, Christopher Mirabelli, Ph.D. ×3 başvurular | 03 Ağustos 2009 | — | İlk başvuru | — | SEC |
| Bear Stearns Health Innoventures, L.P., Bear Stearns Health Innoventures Offshore, L.P., BX, L.P., Bear Stearns Health Innoventures Employee Fund, L.P., BSHI Members, L.L.C., Bear Stearns Health Innoventures Management, L.L.C., Bear Stearns Asset Management Inc. ×3 başvurular | 29 Mayıs 2009 | — | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Integrated Core Strategies (US) LLC, Riverview Group LLC, Millennium Management LLC, Israel A. Englander ×2 başvurular | 23 Nisan 2009 | — | İlk başvuru | — | SEC |
| Nexia Biotechnologies Ltd. | 30 Mayıs 2008 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 17 Ağustos 2007 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 14 Ağustos 2007 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 32 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 36.663 SH | 08 Ağustos 2026 | Günlük |
| BBC · ETFis Series Trust I | 0,36% | 52.374 NS | 30 Nisan 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,25% | 134.076 NS | 31 Mayıs 2026 | N-PORT |
| IWC · iShares Trust | 0,14% | 673.112 SH | 08 Ağustos 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,12% | 248.923 NS | 30 Nisan 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 1.339.073 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 10.586 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 172.834 SH | 08 Ağustos 2026 | Günlük |
| IWN · iShares Trust | 0,04% | 1.851.172 SH | 08 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.142.675 SH | 08 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 183.761 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,02% | 4.631 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 5.057.242 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 56.560 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.235.429 SH | 08 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,01% | 6.144 NS | 31 Mayıs 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 569.267 SH | 08 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 414.821 NS | 30 Nisan 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 4.804 NS | 31 Mayıs 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4.861 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 122 NS | 31 Mayıs 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 358.663 SH | 08 Ağustos 2026 | Günlük |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.514 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 8.167 NS | 30 Nisan 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 763 NS | 31 Mayıs 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23.287 SH | 08 Ağustos 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 25.408 NS | 30 Nisan 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9.653 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 34.439 NS | 30 Nisan 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.748.771 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 16.865 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 353 NS | 31 Mayıs 2026 | N-PORT |